Caribou Biosciences, Inc. Banner Image

Caribou Biosciences, Inc.

  • Ticker CRBU
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Caribou Biosciences, Inc. Logo Image
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve antitumor activity. Caribou is advancingMore a pipeline of off-the-shelf cell therapies from its CAR-T and CAR-NK platforms as readily available treatments for patients with hematologic malignancies and solid tumors.
Caribou Biosciences, Inc.

Most Recent Annual Report

Caribou Biosciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Caribou Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!